CompletedNot Applicable

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

United States829 participantsStarted 2020-06-23

Plain-language summary

The primary objective is to assess the ability of COVID-19 IgG and IgM assays to detect an immune response in COVID-19 patients in the Henry Ford Health System (HFHS), both during hospitalization and over the following 12 months.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ≥18 years of age * Positive COVID-19 by RT-PCR SARS-CoV-2 assay * Patients must have a serum sample stored by pathology or within the TCRC biorepository around the date of their COVID-19 RT-PCR positive test Exclusion Criteria: * \< 18 years of age * negative for RT-PCR * no serum sample

What they're measuring

Detection of antibodies to SARS-CoV-2 in human serum and plasma

Timeframe: 12 months

Trial details

NCT IDNCT04562285

SponsorHenry Ford Health System

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05-28

View on ClinicalTrials.gov More Covid19 trials